Suspending Rules 24(c), 35, 41(b), and 42(e), Uniform Rules of the Alaska State Legislature, concerning House Concurrent Resolution No. 4, proclaiming May 2025 as Myositis Awareness Month.

34th Legislature (2025-2026)

Suspends certain legislative rules to allow changes to the title of House Concurrent Resolution No. 4 so May 2025 is proclaimed as Myositis Awareness Month.

(S) LEGISLATIVE RESOLVE NO. 59

#families #health&socialservices #medicalcare #proclamations #uniformrules

Summary of SCR 16 (Session 34, Alaska)

Purpose and intent

SCR 16 is a Senate Concurrent Resolution that seeks to suspend specific procedural rules of the Alaska State Legislature to facilitate consideration of House Concurrent Resolution No. 4.

The ultimate aim is to proclaim May 2025 as Myositis Awareness Month.

Key provisions

The resolution suspends certain Uniform Rules of the Alaska State Legislature:

Rules 24(c)
Rule 35
Rule 41(b)
Rule 42(e)

The suspension is described as being under Rule 54 of the Uniform Rules.

The procedural effect is to allow changes to the title of a bill (a typical procedural barrier) to be bypassed or altered in the consideration of House Concurrent Resolution No. 4.

What would be affected

Legislative process for House Concurrent Resolution No. 4:

By suspending the specified rules, the body intends to permit adjustments related to the title or labeling of HCR 4 without being constrained by the usual title-change restrictions.

The substantive outcome remains the proclamation of May 2025 as Myositis Awareness Month, which is a ceremonial/recognition action rather than a substantive policy or funding measure.

Procedural and timeline aspects

Action history:

March 30, 2026: Read the first time and then held on the Secretary’s desk.
May 20, 2026: Passed in the Senate (S) with a vote of 20 yeas; no opposing vote recorded in the summary (N- not specified as yes/no).

The bill’s passage indicates Senate support for proceeding with HCR 4 and the associated title-change suspension to advance the recognition timely.

By suspending the specified rules, the Legislature clears a potential procedural hurdle to ensure May 2025 (note: there appears to be a discrepancy in dates between the bill’s intended designation (May 2025) and the action dates in 2026; the bill text specifies May 2025 as the awareness month to be proclaimed).

Overall impact

The bill does not create or allocate funding, new programs, or regulatory changes.

It primarily affects legislative procedure to enable HCR 4 to proceed with the intended proclamation.

The substantive public impact is ceremonial/awareness-oriented, focusing on recognizing Myositis Awareness Month in May.